LanzaTech Global 2025 Q3 Earnings 105% Net Income Turnaround Amid Revenue Dip

LanzaTech Global (LNZA) reported fiscal 2025 Q3 earnings on November 19, 2025, with total revenue declining 6.7% year-over-year to $9.28 million. Despite the revenue contraction, the company returned to profitability with a $2.86 million net income, marking a 105% improvement from a $57.43 million loss in 2024 Q3. Management highlighted strategic cost cuts and a non-cash gain on financial instruments as key contributors to the turnaround.

Revenue

LanzaTech’s Q3 revenue of $9.28 million reflected a 6.7% decline from $9.94 million in the prior-year period. Biorefining revenue stood at $5.09 million, while engineering and other services accounted for $4.04 million. Licensing and joint development agreements generated $1.05 million and $62,000, respectively, and contract research revenue totaled $1.16 million. CarbonSmart products contributed $2.97 million, rounding out the total.

Earnings/Net Income

The company achieved a dramatic turnaround in profitability, reporting a net income of $2.86 million in Q3 2025 versus a $57.43 million loss in the prior-year period. Earnings per share (EPS) surged to $1.14 from a $29.04 loss, reflecting a 103.9% positive change. The 105% net income improvement underscores a significant reversal of fortune after four consecutive years of quarterly losses.

Price Action

LNZA’s stock price declined 0.23% on the latest trading day, fell 27.89% for the week, and dropped 53.23% month-to-date.

Post-Earnings Price Action Review

The strategy of buying LNZA shares on revenue release days and holding for 30 days demonstrated robust performance over three years. Investors capitalized on 75% of positive stock price movements on revenue release days, with 50% of those gains extending into the 30-day holding period. This approach outperformed the broader market, aligning with the company’s growth trajectory.

CEO Commentary

Dr. Jennifer Holmgren emphasized a “year of disciplined transformation,” citing cost optimization, headcount reductions, and a focus on sustainable aviation fuel (SAF) as key drivers. She highlighted a non-cash gain on financial instruments and reduced operating expenses as critical to the Q3 turnaround, while noting the need for capital to advance SAF strategies.

Guidance

LanzaTech expects to finalize a €40 million EU Innovation Fund grant by spring 2026 for a Norway-based CCUS project and anticipates further cost reductions. However, short-term restructuring costs and reliance on government funding remain risks.

Additional News

LanzaTech’s joint venture, LanzaJet, began full operations at its Georgia-based Freedom Pines Fuels facility in November 2025, marking the world’s first commercial-scale ethanol-to-jet fuel production. The company also secured a €40 million EU grant for a Norway-based integrated CCUS facility, expected to produce 23.5 kt of ethanol annually. Cost optimization initiatives reduced operating expenses by 48.3% year-over-year to $18.0 million, though cash reserves declined to $23.5 million as of September 30, 2025.